NCT00046072View on ClinicalTrials.gov

A Safety and Efficacy Study of Intravenous E5564 in Patients With Severe Sepsis

PHASE2CompletedINTERVENTIONAL

Enrollment

300

Participants

Timeline

Start Date

October 31, 2001

Study Completion Date

April 30, 2005

Conditions

SepsisShock, SepticSepsis SyndromeSepticemiaInfection

Interventions

DRUG

E5564

Trial Locations (17)

11030

Manhasset

14203

Buffalo

31902

Columbus

32209

Jacksonville

32504

Pensacola

33125

Miami

36608

Mobile

60007

Elk Grove

66160

Kansas City

73104

Oklahoma City

75390

Dallas

77555

Galveston

78229

San Antonio

92134

San Diego

93105

Santa Barbara

02114

Boston

01199

Springfield

All Listed Sponsors

lead

Eisai Inc.

INDUSTRY

NCT00046072 - A Safety and Efficacy Study of Intravenous E5564 in Patients With Severe Sepsis | Biotech Hunter | Biotech Hunter